Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$11.96 1.1%
Market Cap
$101.1M
Price Target
Refer to Report
Volume
4.1K
52wk Range
$4.5601 - $76
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.